283 related articles for article (PubMed ID: 30192772)
1. Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
Bozio CH; Abdul-Karim A; Abenyeri J; Abubakari B; Ofosu W; Zoya J; Ouattara M; Srinivasan V; Vuong JT; Opare D; Asiedu-Bekoe F; Lessa FC
PLoS One; 2018; 13(9):e0203205. PubMed ID: 30192772
[TBL] [Abstract][Full Text] [Related]
2. An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana.
Kwambana-Adams BA; Asiedu-Bekoe F; Sarkodie B; Afreh OK; Kuma GK; Owusu-Okyere G; Foster-Nyarko E; Ohene SA; Okot C; Worwui AK; Okoi C; Senghore M; Otu JK; Ebruke C; Bannerman R; Amponsa-Achiano K; Opare D; Kay G; Letsa T; Kaluwa O; Appiah-Denkyira E; Bampoe V; Zaman SM; Pallen MJ; D'Alessandro U; Mwenda JM; Antonio M
BMC Infect Dis; 2016 Oct; 16(1):575. PubMed ID: 27756235
[TBL] [Abstract][Full Text] [Related]
3. Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010-2018.
Ousmane S; Kobayashi M; Seidou I; Issaka B; Sharpley S; Farrar JL; Whitney CG; Ouattara M
Vaccine; 2020 May; 38(23):3922-3929. PubMed ID: 32327220
[TBL] [Abstract][Full Text] [Related]
4. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.
Soeters HM; Kambiré D; Sawadogo G; Ouédraogo-Traoré R; Bicaba B; Medah I; Sangaré L; Ouédraogo AS; Ouangraoua S; Yaméogo I; Congo-Ouédraogo M; Ky Ba A; Aké F; Srinivasan V; Novak RT; McGee L; Whitney CG; Van Beneden C
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S253-S262. PubMed ID: 31671444
[TBL] [Abstract][Full Text] [Related]
5. Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.
Kambiré D; Soeters HM; Ouédraogo-Traoré R; Medah I; Sangare L; Yaméogo I; Sawadogo G; Ouédraogo AS; Hema-Ouangraoua S; McGee L; Srinivasan V; Aké F; Congo-Ouédraogo M; Sanou S; Ba AK; Novak RT; Van Beneden C;
PLoS One; 2016; 11(11):e0166384. PubMed ID: 27832151
[TBL] [Abstract][Full Text] [Related]
6. Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015.
Kambiré D; Soeters HM; Ouédraogo-Traoré R; Medah I; Sangaré L; Yaméogo I; Sawadogo G; Ouédraogo AS; Ouangraoua S; McGee L; Srinivasan V; Aké F; Congo-Ouédraogo M; Ky Ba A; Whitney CG; Novak RT; Van Beneden C;
J Infect; 2018 Mar; 76(3):270-279. PubMed ID: 29253559
[TBL] [Abstract][Full Text] [Related]
7. [A pediatric case of pneumococcal meningitis due to Streptococcus pneumoniae serotype 35F].
Kara SS; Polat M; Tapisiz A; Nar Otgun S; Tezer H
Mikrobiyol Bul; 2014 Apr; 48(2):346-50. PubMed ID: 24819273
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009.
Gessner BD; Sanou O; Drabo A; Tamekloe TA; Yaro S; Tall H; Moïsi JC; Mueller JE; Njanpop-LaFourcade BM
Vaccine; 2012 Dec; 30 Suppl 6():G41-5. PubMed ID: 23228357
[TBL] [Abstract][Full Text] [Related]
9. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
10. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children.
Ruiz-Contreras J; Picazo J; Casado-Flores J; Baquero-Artigao F; Hernández-Sampelayo T; Otheo E; Méndez C; Del Amo M; Balseiro C;
Vaccine; 2017 Aug; 35(35 Pt B):4646-4651. PubMed ID: 28711388
[TBL] [Abstract][Full Text] [Related]
11. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo.
Traore Y; Tameklo TA; Njanpop-Lafourcade BM; Lourd M; Yaro S; Niamba D; Drabo A; Mueller JE; Koeck JL; Gessner BD
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S181-9. PubMed ID: 19191614
[TBL] [Abstract][Full Text] [Related]
12. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children.
Olarte L; Barson WJ; Barson RM; Lin PL; Romero JR; Tan TQ; Givner LB; Bradley JS; Hoffman JA; Hultén KG; Mason EO; Kaplan SL
Clin Infect Dis; 2015 Sep; 61(5):767-75. PubMed ID: 25972022
[TBL] [Abstract][Full Text] [Related]
13. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL
Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276
[TBL] [Abstract][Full Text] [Related]
14. Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018.
Njuma Libwea J; Fletcher MA; Koki Ndombo P; Boula A; Ashukem NT; Ngo Baleba M; Kingue Bebey RS; Nkolo Mviena EG; Tageube J; Kobela Mbollo M; Koulla-Shiro S; Madhi S; Njanpop-Lafourcade BM; Mohammad A; Begier E; Southern J; Beavon R; Gessner B
PLoS One; 2021; 16(4):e0250010. PubMed ID: 33857235
[TBL] [Abstract][Full Text] [Related]
15. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
Kaplan SL; Barson WJ; Lin PL; Romero JR; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
Pediatr Infect Dis J; 2013 Mar; 32(3):203-7. PubMed ID: 23558320
[TBL] [Abstract][Full Text] [Related]
16. African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults.
Gessner BD; Mueller JE; Yaro S
BMC Infect Dis; 2010 Feb; 10():22. PubMed ID: 20146815
[TBL] [Abstract][Full Text] [Related]
17. Estimating the economic burden of pneumococcal meningitis and pneumonia in northern Ghana in the African meningitis belt post-PCV13 introduction.
Kobayashi M; Abdul-Karim A; Milucky JL; Zakariah A; Leidner AJ; Asiedu-Bekoe F; Opare D; Eleeza JB; Ofosu W; Walker C; Whitney CG; Lessa FC
Vaccine; 2021 Jul; 39(33):4685-4699. PubMed ID: 34218962
[TBL] [Abstract][Full Text] [Related]
18. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years-Zimbabwe, 2010-2016.
Dondo V; Mujuru H; Nathoo K; Jacha V; Tapfumanei O; Chirisa P; Manangazira P; Macharaga J; de Gouveia L; Mwenda JM; Katsande R; Weldegebriel G; Pondo T; Matanock A; Lessa FC
Clin Infect Dis; 2019 Sep; 69(Suppl 2):S72-S80. PubMed ID: 31505631
[TBL] [Abstract][Full Text] [Related]
20. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
